Matches in Nanopublications for { ?s ?p "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP869476.RAgH0JhisZan8Klbgt-YHCkDFKOgernpMq8IjqVwugqOU130_assertion description "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869476.RAgH0JhisZan8Klbgt-YHCkDFKOgernpMq8IjqVwugqOU130_provenance.
- NP654710.RArjNoGfGcyPdhdAZ07BCBKtHav5LzilsZvO4wRT9D3Q8130_assertion description "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654710.RArjNoGfGcyPdhdAZ07BCBKtHav5LzilsZvO4wRT9D3Q8130_provenance.
- assertion description "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP348308.RAV8xK6dt1ReW-8hRSKSHAtPgjcgP3HoKWuGA2Ifo3R8c130_assertion description "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348308.RAV8xK6dt1ReW-8hRSKSHAtPgjcgP3HoKWuGA2Ifo3R8c130_provenance.
- NP348378.RAvUUv41JPK7pP-susBC1mKQHdZCNps_TpaxztngTlp6g130_assertion description "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348378.RAvUUv41JPK7pP-susBC1mKQHdZCNps_TpaxztngTlp6g130_provenance.
- NP372904.RAjxOohFkCPfeEb2XgEUeyfTCUgWa3J3mGP7_LulVQ7eA130_assertion description "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372904.RAjxOohFkCPfeEb2XgEUeyfTCUgWa3J3mGP7_LulVQ7eA130_provenance.
- NP372906.RAL8QIVGPZoDIi4P_1neCwMCngULPpmaVZyHxXdKa4r3s130_assertion description "[An oligonucleotide microarray screen (Affymetrix) comparing patients with MLL gene-rearranged ALL with those with nonrearranged ALL also showed a 1.9-fold lower dCK (P =.001) and a 2.7-fold higher hENT1 (P =.046) mRNA expression in patients with MLL gene-rearranged ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372906.RAL8QIVGPZoDIi4P_1neCwMCngULPpmaVZyHxXdKa4r3s130_provenance.